Professor Alain Blanchard from INRA Bourdeaux and Dr. Hubert Bernauer, CEO of the SME ATG:biosynthetics GmbH, participated as invited speakers in this workshop which was organised by the Directorate-General for Research and Innovation of the European Commission.
The main aim of the workshop was to promote debates on how to maximize the anticipated impact of research and innovation projects by applying Key Enabling Technologies (KETs). In that sense, MycoSynVac partners explained which is our startegy on identifying, evaluate, protect and eventually exploit all finding arising from the project, both those originally planned and new ones that may appear during its implementation. Dr. Bernauer as manager of one of the industrial partners of the project explained in further detail what are the benefits for that German SME.
The event chaired by José-Lorenzo Vallés, Head of Unit at DG RTD, was introduced by Peter Dröll, director for Industrial Technologies at the EC, and was attended by some 17 EU-funded projects in which biotechnology is a driving force, and was a good opportunity to share good practices to maximize project impact, and explore new networks.